A semi-quantitative ELISA for complement-fixing, IgG-containing immune complexes (IC) is described. The assay is based on the insolubilization of IC by polyethyleneglycol, their capture by solid-phase anti-C3 antibodies, reaction with peroxidase-labeled anti-IgG antibodies and incubation with a chromogenic peroxidase substrate. It was markedly improved by the use of a single-step procedure which simultaneously washed and precipitated the insolubilized immune complexes. Intra-assay and inter-assay coefficients of variation were lower than 8.6 and 14.7%, respectively. As expected, higher levels of circulating immune complexes, in relation to healthy individuals, were found in patients with American visceral leishmaniasis (AVL), systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), with prevalences comparable to those described in the literature. The ELISA can be quickly assembled from reagents and plasticware widely available commercially, detects immune complexes fulfilling three different criteria and is more sensitive than a previously published 21 method based on the same principles (detection limit for complement-sensitized aggregated IgG of 2 mg ml as compared 21 with a detection limit above 16 mg ml ).
Introduction
on humoral and cellular immune responses (RamosNiembro et al., 1982; Adyel et al., 1996 ; Berger et Immune complexes (IC) participate in the pathoal., 1997; Quayle et al., 1997) . The quantification of genesis of many diseases and exert profound effects circulating immune complexes (CIC) in patients with inflammatory processes has been used both for diagnosis and determination of disease activity
Abbreviations: agIgG, complement-sensitized aggregated IgG; (Huber et al., 1989; Basson et al., 1991 In the present study, an ELISA for the semi- quantification of soluble immune complexes was serum, as a source of complement. This was stored developed. To produce a signal in it, the complexes in small aliquots at 2208C prior to use. had to fulfill three different criteria, namely to be insoluble in 2.5% polyethylene glycol (PEG) and to 2.3. Insolubilization of CIC and agIgG contain IgG and C3 epitopes.
The ELISA resulted from a combination of two CIC and agIgG were insolubilized by PEG (PEG previously published assays (Pontes de Carvalho et 6000; Sigma Chemical Co., St. Louis, MO), as al., 1986; Xu and Gu, 1990) , preserving their best previously described (Pontes de Carvalho et al., features. Radiation hazards were avoided by the use 1986). Briefly, 100 ml of neat serum or agIgG of peroxidase-labeled instead of radiolabeled antidilutions were mixed by inversion with an equal bodies; a one-step centrifugation procedure was used volume of 0.3 M borate buffer, pH 8.3 (BB), to wash insolubilized CIC, minimizing losses and containing 0.1 M EDTA and 5% PEG, overnight, at variability due to multiple centrifugations. The assay 48C. The mixtures were diluted 1:3 in BB containing was demonstrated herein by its application to the 0.002% phenol red and 2.5% PEG, previous to being detection of CIC in patients with American visceral tested for the presence of insoluble CIC or agIgG, so leishmaniasis (AVL), systemic lupus erythematosus that the final serum dilution was 1:6. (SLE) and rheumatoid arthritis (RA).
Quantification of IgG
In order to exclude the possibility that the pro-2. Materials and methods cedure described above could insolubilize free IgG, normal human serum was treated as described with 2.1. Human sera 2.5% PEG and centrifuged for different periods of time. The amounts of IgG present in the precipitates Sera from 53 patients with AVL (with diagnoses were then measured in an ELISA. The ELISA was confirmed by direct identification of the parasite), 85 based on the competition for an anti-IgG-peroxidase with SLE and 14 with RA, and from 74 healthy conjugate of the test IgG with microtiter well-bound volunteers, were studied. Diagnoses of SLE and RA IgG (Barros et al., manuscript in preparation). were made in accordance with criteria proposed by the American Rheumatism Association (Arnett et al., 2.5. One-step centrifugation procedure for both 1988). All volunteers were previously informed on precipitating and washing insolubilized CIC and and understood the nature of the research; patient's agIgG sera consisted of small volumes (100 ml) necessarily remaining from serum aliquots obtained for clinical
The insolubilized complexes were simultaneously reasons.
precipitated and washed by a previously described method (Pontes de Carvalho et al., 1986) , slightly 2.2. Complement-sensitized heat-aggregated modified. Briefly, 900 ml of BB containing 6% immunoglobulin powdered skimmed milk (w / v) and 2.5% PEG (BBmilk-PEG) were placed into 1.5 ml conical-bottom
21
IgG (1 mg ml ) was purified from normal human microcentrifuge plastic tubes (Thomas Scientific, serum by affinity chromatography on a protein APhiladelphia, PA). Approximately 4 cm-long plastic Sepharose CL 4B column (Amersham Pharmacia cylinders were made out of 1000 ml automatic Biotech AB, Uppsala, Sweden), and aggregated by pipette tips (Universal Fit Pipette Tips; Corning incubation at 638C for 30 min. Complement-senCostar Corporation, Cambridge, MA) by cutting off sitized aggregated IgG (agIgG), used to obtain their conical points. These cylinders were introduced standard curves, were formed by diluting aggregated as much as possible into the microcentrifuge tubes IgG in 0.15 M phosphate-buffered saline, pH 7.2 containing BB-milk-PEG, so that about half cylinder (PBS), containing 7.5% of fresh normal human length remained outside the tubes, and the BB-milk-PEG filled the cylinder lowest part up to approxia 1:5.000 dilution of peroxidase-labeled anti-human mately 1 cm. Subsequently, 100 ml of the redIgG (g-chain specific; Sigma Chemical Co., St. colored serum or agIgG dilutions were placed over Louis, MO) were added to each well, followed by 1 the BB-milk-PEG surface within the plastic cylinh incubation at 378C. The plates were then washed ders, in duplicates. After centrifugation (36003g, 30 three times as described above and 100 ml of a min), the upper opening of the cylinders were airperoxidase substrate (ortophenylenodiamine and hytightly blocked by the assayer's index finger, who, drogen peroxide) solution were added to each well. by holding the cylinders between thumb and middle After incubation at 378C for 20 min, the reaction was finger, withdrew them from the tubes, together with stopped by the addition of 25 ml of 2 M H SO and 2 4 the red-colored serum or agIgG supernatants. In this the optical density (OD) read at 490 nm. Results
way, no soluble material from the serum or agIgG were expressed as equivalents to mg of agIgG ml 21 dilutions ever entered the microcentrifuge tubes, (eq. mg agIgG ml ). Values above the mean of the precluding the need for washing the precipitates by results obtained from 75 healthy individuals' sera successively filling up and centrifuging the tubes.
plus three standard deviations of the mean were After removing the cylinders, most of the remaining considered as being positive. BB-milk-PEG solution was discarded by aspiration through a Pasteur pipette connected to a vacuum 2.7. Comparison between two anti-C3 /IgG assays pump, leaving the washed precipitates and about 220
for immune complexes ml of BB-milk-PEG inside the tubes. The length of the Pasteur pipette that was allowed to enter the In accordance with a previously published prototubes was determined by a small rubber cap attached col (Xu and Gu, 1990) , increasing amounts of agIgG to the pipette tip (attachment was accomplished by were insolubilized in 2000 ml of a 1:40 human serum simply leaving a perforated cap as a rubber ring dilution containing 2.5% of PEG. Also following Xu around the pipette tip). Insolubilized IC from some and Gu's methodology (Xu and Gu, 1990) , the sera were washed with BB-milk-PEG also in the precipitates obtained after centrifugation were not classical way, i.e. by means of three centrifugations washed. The same amounts of agIgG were tested in for 10 min at 15 0003g. parallel in the assay described herein, which uses a one-step washing procedure and much smaller vol-2.6. Detection of umes (100 ml) of less diluted (1:6) serum. The complexes precipitates were then assayed for the presence of complexes containing both C3 and IgG epitopes as This was performed as follows. Wells of microtiter described above. plates (Corning, NY) were coated with goat anti-C3 antibodies (serum globulin fraction; Sigma Chemical Co., St. Louis, MO) through overnight incubation at 3. Results 48C with 100 ml of 0.06 M sodium carbonate-21 bicarbonate buffer, pH 9.6, containing 30 mg ml of the antibody preparation. After incubation, the wells 3.1. Detection of different amounts of aggregated were blocked by incubation for 1 h at 378C with 100
IgG by anti-C3 /IgG ELISA ml of PBS containing 5% skimmed milk and washed three times with PBS containing 0.05% Tween 20
AgIgG in amounts varying from 1.25 to 80 mg (PBS-T). Then 100 ml of washed PEG precipitates in was diluted with PBS containing 7.5% normal BB-milk-PEG were added to the wells. On each human serum and 100 ml aliquots were tested in the plate, a set of wells contained double dilutions of assay in duplicates. There was a linear relationship PEG-precipitated agIgG (1.25-80 mg of protein between added agIgG and the optical densities 21 ml ) or BB-milk-PEG alone. The plates were then obtained in the ELISA (Fig. 1 ). Wells coated with incubated for 1 h at 378C and 1 h at 48C, followed by bovine serum albumin or normal goat IgG instead of three washings with PBS-T. Subsequently, 100 ml of anti-C3 produced optical densities similar to wells in centrifugation, 99.03% after 10 min, 98.86% after 15 min, 98.94% after 20 min and 99.06% after 30 min).
Comparison between two washing procedures for insoluble immune complexes
To find out whether the one-step washing procedure produced better results than a classical threecentrifugation washing procedure, 10 AVL patient's sera and two normal human sera were tested employing each type of washing in parallel. The one-step washing procedure led to significantly higher IC levels in the patients' sera than the three-centrifugation washing procedure (P,0.005; Wilcoxon's nonparametric ranking test for paired samples), without increasing the values obtained with the normal sera (Fig. 2) .
Reproducibility of the assay
The inter-assay coefficient of variation, obtained by testing three sera in five different assays, was which no serum or agIgG was added (ranging from 0.034 to 0.039).
Assessment of IgG solubility in 2.5% of PEG
False-positive results could be produced in the assay described above if free IgG with rheumatoid factor activity was precipitated by 2.5% PEG, since it would recognize as antigen the heterologous anti- 7.9% for a medium (209616.6 mg ml ) and 8.2% 21 for a low (58.264.8 mg ml ) concentration of CIC. To determine the intra-assay coefficient of variation, eight replicates of two sera were tested in the same assay. It was found to be 8.6% for a medium 21 (225.5619.5 mg ml ) concentration and 7.1% for a 21 low (46.663.3 mg ml ) concentration of CIC.
Comparison between two anti-C3 /IgG assays for immune complexes
The assay employing the single-step washing 16 mg ml (Fig. 3) .
value of the results obtained from 75 normal human sera plus three standard deviations of the mean. IC amounts were measured in 100 ml volumes of 1:6-diluted serum, corrected for the dilution factor and expressed as equivalents to mg of aggregated IgG per 21 ml (eq. mg agIgG ml ), as described in the Materials and methods section.
Detection of CIC in patients with different diseases
The assay disclosed significantly higher levels (Fig. 4) and prevalence (Table 1) of CIC in patients with AVL, RA or SLE in relation to a normal control group.
Discussion
Most assays employed for quantifying CIC have important drawbacks, leading to widely discrepant percentages of patients in whom CIC are detected (Lambert, 1978) . This has been ascribed to variations in CIC sizes and in their contents of antibodies, bodies through a reactive carboxyl group. a CIC concentrations were measured in 100 ml volumes of 1:6-diluted serum, corrected for the dilution factor and expressed as equivalents to mg of aggregated IgG per ml, as described in the Material and methods section.
b Sera with concentrations of CIC higher than the mean of the concentrations from 75 normal controls plus three standard deviations of the mean were considered positive.
c Mean value of CIC concentrations in the group6standard deviation of the mean.
In this work anti-C3 antibodies were used to detect better results than a classical three-step washing complement-fixing CIC, which are probably the most procedure, increasing the amounts of IC detected in pathogenic IC because of the pro-inflammatory AVL patients' sera and not affecting the results properties of complement (Bourke et al., 1982) . As obtained with normal human sera. This could be little as 2 mg of heat-aggregated IgG per ml could be explained by a probable loss of immune complexes detected. This indicates a considerably higher sendue to multiple washings. sitivity than that of a previously published anti-C3
The percentages of patients with AVL (88%), SLE ELISA, based on identical principles and using the (44%) and RA (77%) that had CIC as determined by same reagents (Xu and Gu, 1990) The concentration of PEG used in this assay advantage of the assay described herein over the one (2.5%) does not precipitate IgG-C3 complexes (Xu proposed by Xu and Gu (1990) is that it does not and Gu, 1990) and free IgG (this paper). The 2.5% require the preparation of F(ab9) . The use of F(ab9) PEG-precipitated material containing IgG and C3 2 2 in the solid phase is justified in terms of avoiding epitopes detected in the assay described herein, false positive results due to free anti-Fc IgM therefore, can only be ascribed to CIC. rheumatoid factors, which reacts with heterologous
The ELISA described herein has one or more of IgG and would form bridges between the anti-C3 the following advantages over other available assays: antibody and the anti-immunoglobulin-peroxidase
(1) CIC have to fulfill three different criteria in order conjugate. These factors do not interfere with the to be detected; (2) it uses a virtually failure-proof present assay for two reasons: (1) a d chain-specific procedure for washing insolubilized IC, which anti-IgG conjugate is used; and (2) free IgM avoids both contamination with soluble material due rheumatoid factor does not precipitate in 2.5% PEG to insufficient washing and loss of IC due to (Baldwin et al., 1982) . PEG-precipitable IC conaspiration of supernatants or adsorption to centrifuge taining IgM rheumatoid factor, its IgG antigen and tube walls; (3) it detects only complement-fixing, C3b would of course be appropriately detected in potentially pathogenic immune complexes; and (4) it both assays. uses relatively inexpensive and widely available The one-step washing procedure also produced reagents and plasticware.
immunosorbent assay for the detection of circulating immune
